Anlotinib and Benmelstobart

DRUG2 trials

Sponsors

Sun Yat-sen University, Fudan University

Conditions

PheochromocytomaThyroid Cancer

Phase 2

Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma

Not yet recruitingNCT06429397

Sun Yat-sen UniversityPheochromocytoma

Start: 2025-05-01End: 2027-05-28Target: 22Updated: 2025-04-29

Anlotinib and Benmelstobart in DTC

Not yet recruitingNCT07193186

Fudan UniversityThyroid Cancer

Start: 2026-04-01End: 2030-12-31Target: 23Updated: 2026-02-27